595 related articles for article (PubMed ID: 28103571)
1. Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells.
Roos A; Dhruv HD; Mathews IT; Inge LJ; Tuncali S; Hartman LK; Chow D; Millard N; Yin HH; Kloss J; Loftus JC; Winkles JA; Berens ME; Tran NL
Oncotarget; 2017 Feb; 8(7):12234-12246. PubMed ID: 28103571
[TBL] [Abstract][Full Text] [Related]
2. SGEF Is Regulated via TWEAK/Fn14/NF-κB Signaling and Promotes Survival by Modulation of the DNA Repair Response to Temozolomide.
Ensign SP; Roos A; Mathews IT; Dhruv HD; Tuncali S; Sarkaria JN; Symons MH; Loftus JC; Berens ME; Tran NL
Mol Cancer Res; 2016 Mar; 14(3):302-12. PubMed ID: 26764186
[TBL] [Abstract][Full Text] [Related]
3. The Src homology 3 domain-containing guanine nucleotide exchange factor is overexpressed in high-grade gliomas and promotes tumor necrosis factor-like weak inducer of apoptosis-fibroblast growth factor-inducible 14-induced cell migration and invasion via tumor necrosis factor receptor-associated factor 2.
Fortin Ensign SP; Mathews IT; Eschbacher JM; Loftus JC; Symons MH; Tran NL
J Biol Chem; 2013 Jul; 288(30):21887-97. PubMed ID: 23775076
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-like weak inducer of apoptosis stimulation of glioma cell survival is dependent on Akt2 function.
Fortin SP; Ennis MJ; Savitch BA; Carpentieri D; McDonough WS; Winkles JA; Loftus JC; Kingsley C; Hostetter G; Tran NL
Mol Cancer Res; 2009 Nov; 7(11):1871-81. PubMed ID: 19861406
[TBL] [Abstract][Full Text] [Related]
5. Cdc42 and the guanine nucleotide exchange factors Ect2 and trio mediate Fn14-induced migration and invasion of glioblastoma cells.
Fortin SP; Ennis MJ; Schumacher CA; Zylstra-Diegel CR; Williams BO; Ross JT; Winkles JA; Loftus JC; Symons MH; Tran NL
Mol Cancer Res; 2012 Jul; 10(7):958-68. PubMed ID: 22571869
[TBL] [Abstract][Full Text] [Related]
6. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
Tran NL; McDonough WS; Savitch BA; Sawyer TF; Winkles JA; Berens ME
J Biol Chem; 2005 Feb; 280(5):3483-92. PubMed ID: 15611130
[TBL] [Abstract][Full Text] [Related]
7. Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis.
Dhruv H; Loftus JC; Narang P; Petit JL; Fameree M; Burton J; Tchegho G; Chow D; Yin H; Al-Abed Y; Berens ME; Tran NL; Meurice N
J Biol Chem; 2013 Nov; 288(45):32261-32276. PubMed ID: 24056367
[TBL] [Abstract][Full Text] [Related]
8. The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance.
Hersh DS; Harder BG; Roos A; Peng S; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA
Neuro Oncol; 2018 Sep; 20(10):1321-1330. PubMed ID: 29897522
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioblastoma cell chemotaxis via Lyn activation.
Dhruv HD; Whitsett TG; Jameson NM; Patel F; Winkles JA; Berens ME; Tran NL
Carcinogenesis; 2014 Jan; 35(1):218-26. PubMed ID: 23975833
[TBL] [Abstract][Full Text] [Related]
10. The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics.
Perez JG; Tran NL; Rosenblum MG; Schneider CS; Connolly NP; Kim AJ; Woodworth GF; Winkles JA
Oncogene; 2016 Apr; 35(17):2145-55. PubMed ID: 26300004
[TBL] [Abstract][Full Text] [Related]
11. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways.
Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y
Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440
[TBL] [Abstract][Full Text] [Related]
12. TWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domain.
Brown SA; Cheng E; Williams MS; Winkles JA
PLoS One; 2013; 8(6):e65248. PubMed ID: 23750247
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor inducible (Fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activity.
Salzmann S; Seher A; Trebing J; Weisenberger D; Rosenthal A; Siegmund D; Wajant H
J Biol Chem; 2013 May; 288(19):13455-66. PubMed ID: 23532848
[TBL] [Abstract][Full Text] [Related]
14. TWEAK/Fn14 interaction induces proliferation and migration in human airway smooth muscle cells via activating the NF-κB pathway.
Zhu C; Zhang L; Liu Z; Li C; Bai Y
J Cell Biochem; 2018 Apr; 119(4):3528-3536. PubMed ID: 29143982
[TBL] [Abstract][Full Text] [Related]
15. TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance.
Loftus JC; Dhruv H; Tuncali S; Kloss J; Yang Z; Schumacher CA; Cao B; Williams BO; Eschbacher JM; Ross JT; Tran NL
Mol Cancer Res; 2013 Aug; 11(8):865-74. PubMed ID: 23699535
[TBL] [Abstract][Full Text] [Related]
16. Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappaB and correlate with poor patient outcome.
Tran NL; McDonough WS; Savitch BA; Fortin SP; Winkles JA; Symons M; Nakada M; Cunliffe HE; Hostetter G; Hoelzinger DB; Rennert JL; Michaelson JS; Burkly LC; Lipinski CA; Loftus JC; Mariani L; Berens ME
Cancer Res; 2006 Oct; 66(19):9535-42. PubMed ID: 17018610
[TBL] [Abstract][Full Text] [Related]
17. Functional expression of TWEAK and the receptor Fn14 in human malignant ovarian tumors: possible implication for ovarian tumor intervention.
Gu L; Dai L; Cao C; Zhu J; Ding C; Xu HB; Qiu L; Di W
PLoS One; 2013; 8(3):e57436. PubMed ID: 23469193
[TBL] [Abstract][Full Text] [Related]
18. Regulation of fibroblast growth factor-inducible 14 (Fn14) expression levels via ligand-independent lysosomal degradation.
Gurunathan S; Winkles JA; Ghosh S; Hayden MS
J Biol Chem; 2014 May; 289(19):12976-88. PubMed ID: 24652288
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.
Cherry EM; Lee DW; Jung JU; Sitcheran R
Mol Cancer; 2015 Jan; 14(1):9. PubMed ID: 25622756
[TBL] [Abstract][Full Text] [Related]
20. TWEAK/Fn14 signaling in tumors.
Hu G; Zeng W; Xia Y
Tumour Biol; 2017 Jun; 39(6):1010428317714624. PubMed ID: 28639899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
